All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Everolimus-related unilateral abdominal lymphedema in a renal cancer patient: A case report

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F20%3A00078469" target="_blank" >RIV/00209805:_____/20:00078469 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/20:00117214

  • Result on the web

    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571978/" target="_blank" >https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571978/</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1097/MD.0000000000022634" target="_blank" >10.1097/MD.0000000000022634</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Everolimus-related unilateral abdominal lymphedema in a renal cancer patient: A case report

  • Original language description

    Rationale: Unilateral manifestation of lymphedema during everolimus therapy has been described only rarely, mostly in transplant recipients. Patient concerns: We report the first case of a patient who developed unilateral abdominal lymphedema, during a short period of everolimus treatment for renal cancer. Diagnosis: The abdominal asymmetry occurred only on the right side of the abdomen, neither ultrasound nor CT scan detected ascites but showed enlargement of the abdominal wall. The Naranjo Adverse Drug Reaction Probability scale was evaluated, in this case, a score of 6 indicated a probable adverse reaction to everolimus. Interventions: Discontinuation of everolimus therapy led to immediate alleviation and reduction of the lymphedema, with worsening once again after initiating retreatment with everolimus at a reduced dose. Outcomes: The patient&apos;s lymphedema recovered after discontinuation of everolimus. Lessons: This rare case demonstrates the importance of the selection of mammalian target of rapamycin inhibitors using caution, especially for patients with a high risk of developing lymphedema.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

    <a href="/en/project/LM2018128" target="_blank" >LM2018128: Czech National Node of the European Clinical Research Infrastructure Network</a><br>

  • Continuities

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Medicine (Baltimore)

  • ISSN

    0025-7974

  • e-ISSN

  • Volume of the periodical

    99

  • Issue of the periodical within the volume

    42

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    4

  • Pages from-to

    "e22634"

  • UT code for WoS article

    000589394700033

  • EID of the result in the Scopus database

    2-s2.0-85094221345